DBVT - DBV Technologies stock extends rally to a second day; co announces $194M financing

DBV Technologies (NASDAQ:DBVT) stock continued its rally on Thursday, adding ~28% to $2.31 in mid-day trading, after an 18.3% gain in the previous session. The company earlier in the day said that it was planning to raise $194M in gross proceeds via a private placement in public equity financing. U.S.-listed shares of DBVT had jumped on Wednesday after its phase 3 trial assessing its Viaskin Peanut for the treatment of peanut allergies in toddlers aged 1 to 3 years met its main goal. Brokerage H.C. Wainwright had reiterated its $10 price target on the company after the positive trial, which represented a significant upside to DBVT's last closing price of $1.81. Up to the last closing price, DBVT stock has added 13.1% YTD.

For further details see:

DBV Technologies stock extends rally to a second day; co announces $194M financing